Nautilus Biotechnology Appoints Karen Akinsanya, Ph.D., to Board of Directors
March 31, 2022 16:05 ET
|
Nautilus Biotechnology Inc.
SEATTLE, March 31, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome,...
Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2021 Financial Results
February 24, 2022 06:00 ET
|
Nautilus Biotechnology Inc.
SEATTLE, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule proteome analysis platform, today reported financial...
Nautilus to Participate in the 42nd Annual Cowen Health Care Conference
February 16, 2022 16:05 ET
|
Nautilus Biotechnology Inc.
SEATTLE, Feb. 16, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the...
Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2021 Financial Results on February 24, 2022
January 27, 2022 08:00 ET
|
Nautilus Biotechnology Inc.
SEATTLE, Jan. 27, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the...
Nautilus and Abcam Announce Strategic Partnership to Accelerate Exploration of the Proteome
November 02, 2021 08:00 ET
|
Nautilus Biotechnology Inc.
SEATTLE and CAMBRIDGE, United Kingdom, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis...
Nautilus Biotechnology Reports Third Quarter 2021 Financial Results
November 02, 2021 06:00 ET
|
Nautilus Biotechnology Inc.
SEATTLE, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome,...
Nautilus Biotechnology to Announce Third Quarter of Fiscal Year 2021 Financial Results on November 2, 2021
October 11, 2021 08:00 ET
|
Nautilus Biotechnology Inc.
SEATTLE, Oct. 11, 2021 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the...
Nautilus to Participate in the Morgan Stanley Global Healthcare Conference
September 03, 2021 09:00 ET
|
Nautilus Biotechnology Inc.
SEATTLE, Sept. 03, 2021 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the human...
Nautilus Biotechnology Reports Second Quarter 2021 Financial Results
August 10, 2021 06:00 ET
|
Nautilus Biotechnology Inc.
SEATTLE, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a life sciences company creating a platform technology for quantifying and unlocking the...
Nautilus Biotechnology Appoints Karl Voss, Ph.D., as Vice President of Life Sciences Research and Development
August 09, 2021 08:00 ET
|
Nautilus Biotechnology Inc.
SEATTLE, Aug. 09, 2021 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome,...